Programmed Cell Death-Ligand 1 (PD-L1) in Mismatch Repair Protein Deficient Colon Cancer: An Immunohistochemical and Genomic Profiling Study

被引：0
|
作者：
Lee, Hwajeong
Geiersbach, Katherine
Ainechi, Sanaz
Sheehan, Christine E.
Jones, David M.
Affoltez, Kajsa
Bronnez, Mary P.
Ross, Jeffrey S.
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Univ Utah, Salt Lake City, UT USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
716
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [21] Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer
    Wang, Lisha
    Ren, Fei
    Wang, Qifeng
    Baldridge, Lee Ann
    Monn, M. Francesca
    Fisher, Kurt W.
    Sheng, Weiqi
    Zhou, Xiaoyan
    Du, Xiang
    Cheng, Liang
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (02) : 175 - 181
  • [22] Significance of Programmed Death Ligand 1 (PD-L1) Immunohistochemical Expression in Colorectal Cancer
    Lisha Wang
    Fei Ren
    Qifeng Wang
    Lee Ann Baldridge
    M. Francesca Monn
    Kurt W. Fisher
    Weiqi Sheng
    Xiaoyan Zhou
    Xiang Du
    Liang Cheng
    Molecular Diagnosis & Therapy, 2016, 20 : 175 - 181
  • [23] Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1)
    Michikawa, Chieko
    Gopalakrishnan, Vancheswaran
    Harrandah, Amani M.
    Karpinets, Tatiana, V
    Garg, Rekha Rani
    Chu, Randy A.
    Park, Yuk Pheel
    Chukkapallia, Sasanka S.
    Yadlapalli, Nikhita
    Erikson-Carter, Kelly C.
    Gleber-Netto, Frederico Omar
    Sayour, Elias
    Progulske-Fox, Ann
    Chan, Edward K. L.
    Wu, Xiaogan
    Zhang, Jianhua
    Jobin, Christian
    Wargo, Jennifer A.
    Pickering, Curtis R.
    Myers, Jeffrey N.
    Silver, Natalie
    NEOPLASIA, 2022, 31
  • [24] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    LABORATORY INVESTIGATION, 2019, 99
  • [25] Programmed Death-ligand 1 (PD-L1) Expression in Thymic Epithelial Tumors
    Bedekovics, Judit
    Beke, Livia
    Mokanszki, Attila
    Szilagyi, Szabolcs
    Mehes, Gabor
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) : 1 - 9
  • [26] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [27] Programmed death-ligand 1 (PD-L1) and programmed cell death protein 1 (PD-1) expression in bladder cancer (BC): Differences in recurrent, progressive, and metastatic disease.
    Hegele, Axel
    Wahl, Franziska
    Rexin, Peter
    Nimphius, W.
    Hofmann, Rainer
    Haenze, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [28] Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma
    Richter, Igor
    Jirasek, Tomas
    Cermakova, Eva
    Bartos, Jiri
    Buchler, Tomas
    Dvorak, Josef
    JOURNAL OF BUON, 2019, 24 (05): : 2155 - 2160
  • [29] Programmed death-ligand 1 (PD-L1) expression in small cell carcinoma of bladder.
    Sanguino, Angela
    Samiei, Arash
    Pasricha, Gurleen
    Harinath, Lakshmi
    Miller, Ralph
    Lyne, John
    Silverman, Jan F.
    Mao, Shifeng
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [30] Programmed Death-Ligand 1 (PD-L1) Expression in Pheochromocytoma: Clinicopathologic Correlation
    Xiong, Meng-Jun
    Kissick, Haydn
    Master, Viraj
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2019, 32
12345